Pixyl announced raising €2.2 million in a round led by Elaia.

Pixyl, a Grenoble (La Tronche), France-based developer of AI-based tech solutions for medical radiologists and clinicians, announced the completion of a €2.2 million ($2.6M) capital funding round.

The money was raised from a range of investors from France led by Elaia, alongside new investors Holnest and Bpifrance, as well as an additional 32 radiologists and clinicians as business angels, including Groupe Clinique du Mail.

Proceeds will be used for go-to-market purposes as well as for getting FDA regulatory clearance of the company’s products for future U.S. expansion.

Pixyl, founded in 2015 as a spin-out from the French labs Inria and Inserm by CEO Senan Doyle, Florence Forbes and Michael Dojat, helps radiologists and clinicians by automatically analysing brain imaging exams in a matter of minutes, highlighting anomalies, and extracting clinically-relevant measurements for improved insight and decision-making in patient diagnosis and treatment.

The company also built a proprietary medical device called Pixyl.NeuroTM, which supports radiology workflows in modern healthcare facilities by reducing neuroimaging reporting time and providing actionable insights.

Pixyl has 15 employees and works with 40 customers, public and private imaging centers from France, Spain and Italy.